Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06566534 · ClinicalTrials.gov registry record · NA

Personalized Nudging to Increase Influenza Vaccinations

A NA study, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
77,482
Enrollment target

NCT06566534: Completed NA study, sponsored by Geisinger Clinic.

NCT06566534 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 77,482 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (5427% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06566534, a NA study, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
77,482 participants
Enrollment target

Study Summary

The purpose of this study is to prospectively test whether personalized, message-based nudges can increase flu vaccination compared with nudges that are not personalized or no nudges.

Primary Outcome

Our field experiment will be conducted with Geisinger Health patients via SMS messages sent prior to their first flu shot-eligible appointment during the study period, referred to as the "target appointment." The key dependent variable is whether patients receive a flu shot at or before their target appointment (as recorded in their electronic health records). If patients cancel or do not show up for their target appointment after they have been randomized to a treatment and then schedule a new

Interventions

  • BEHAVIORAL Reminder

Trial Details

FieldValue
Enrollment Target 77,482 participants
Start Date 2024-09-09
Est. Completion 2024-12-31
Phase NA
Geisinger Clinic

107 total trials

What the finished NCT06566534 record still lists

NCT06566534 is an interventional study that assigns participants to a tested intervention. Its 77,482 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (5427% higher).

The record links to 0 conditions, and to 1 intervention - of which Reminder is the first listed.

NCT06566534 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06566534 about?

NCT06566534 is a clinical study titled "Personalized Nudging to Increase Influenza Vaccinations". The purpose of this study is to prospectively test whether personalized, message-based nudges can increase flu vaccination compared with nudges that are not personalized or no nudges.

What is the current status of trial NCT06566534?

This trial is currently completed. It is a NA study. The enrollment target is 77,482 participants. The study started on 2024-09-09. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT06566534?

The interventions under investigation include: Reminder (BEHAVIORAL).

Who is sponsoring clinical trial NCT06566534?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06566534's enrollment target sits among peer trials

77,482 4th of 2000 higher than 1,997 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02402244 · 75,000 participants

    Project: Every Child for Younger Patients With Cancer

  • NCT02803242 · 75,000 participants

    COPD Patient-Powered Research Network

  • NCT04611568 · 75,000 participants · NA

    War on Melanoma™ Public Health & Education Campaign

  • NCT00063063 · 80,000 participants

    Generic Database of Very Low Birth Weight Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06566534, the US trial registry maintained by the National Library of Medicine. NCT06566534 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.